Body mass index and mortality in patients with severe α1-antitrypsin deficiency

Respiratory Medicine

Volumn 91, Issue 2, 1997, Pages 77-82

  Seersholm, N ^a,b  

^a BISPEBJERG HOSPITAL   (Denmark)

^b NONE   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ALPHA 1 ANTITRYPSIN DEFICIENCY; ARTICLE; BODY MASS; BODY WEIGHT; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; EMPHYSEMA; FEMALE; FOLLOW UP; FORCED EXPIRATORY VOLUME; HUMAN; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; REGRESSION ANALYSIS; RISK; SEX DIFFERENCE; SMOKING HABIT; WEIGHT REDUCTION;

EID: 0031019238     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0954-6111(97)90071-8     Document Type: Article

References (14)

1. Seersholm N, Kok-Jensen A. Survival in relation to lung function and smoking cessation of patients with severe hereditary alpha-1-antitrypsin deficiency. Am J Respir Crit Care Med 1995; 151: 369-373.
2. Vandenbergh E, van de Woestijne KP, Gyselen A. Weight changes in the terminal stages of chronic obstructive pulmonary disease. Relation to respiratory function and prognosis. Am Rev Respir Dis 1967; 95: 556-566.
3. Wilson DO, Rogers RM, Wright EC, Anthonisen NR. Body weight in chronic obstructive pulmonary disease. The National Institutes of Health Intermittent Positive-Pressure Breathing Trial. Am Rev Respir Dis 1989; 139: 1435-1438.
4. Fagerhol MK, Cox DW. The Pi polymorphism. Genetic, biochemical and clinical aspects of human alpha 1-antitrypsin. Adv Human Genet 1981; 11: 1-62.
5. Guidelines for the approach to the patient with severe hereditary alpha-1-antitrypsin deficiency. American Thoracic Society. Am Rev Respir Dis 1989; 140: 1494-1497.
6. Quanjer PH. Standardized lung function testing. Report Working Party Standardization of Lung Function Tests, European Community for Coal and Steel. Bull Eur Physiopathol Respir 1983; 19 (Suppl. 5): 1-95.
7. Quanjer PH. Standardized lung function testing. Eur Respir J 1993; 6 (Suppl. 16): 3-102.
8. LeMaistre C, ed. A Statement by the Committee on Standards for Epidemiology Surveys on Chronic Respiratory Disease of the American Thoracic Society. New York: National Tuberculosis and Respiratory Disease Association, 1969, 32 p.
9. Peto R, Pike MC, Armitage P et al. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examples. Br J Cancer 1977; 35: 1-39.
10. Seersholm N, Kok-Jensen A, Dirksen A. Decline in FEV1 among patients with severe hereditary alpha-1-antitrypsin deficiency type PiZ. Am J Respir Crit Care Med 1995; 151: 369-373.
11. Rogers RM, Donahoe M, Costantino J. Physiologic effects of oral supplemental feeding in malnourished patients with chronic obstructive pulmonary disease. A randomized control study. Am Rev Respir Dis 1992; 146: 1511-1517.
12. Shridhar MK. Why do patients with emphysema lose weight? Lancet 1995; 345: 1190-1191.
13. Di Francia M, Barbier D, Mege JL, Orehek J. Tumor necrosis factor-alpha levels and weight loss in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1994; 150: 1453-1455.
14. Filley GF, Beckwitt HJ, Reeves JT, Mitchell RS. Chronic obstructive bronchopulmonary disease. II. Oxygen transport in two clinical types. Am J Med 1968; 44: 26-38.